Akouos, Inc. – NASDAQ:AKUS
Founder-led company
Market closed
Open in 3 days
Akouos stock price monthly change
+0.91%
month
Akouos stock price quarterly change
+289.74%
quarter
Akouos stock price yearly change
+72.82%
year
Akouos key metrics
Market Cap | N/A |
Enterprise value | 450.43M |
P/E | -4.69 |
EV/Sales | N/A |
EV/EBITDA | -5.15 |
Price/Sales | N/A |
Price/Book | 2.71 |
PEG ratio | 0.05 |
EPS | -2.63 |
Revenue | N/A |
EBITDA | -87.43M |
Income | -93.37M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAkouos stock price history
Akouos stock forecast
Akouos financial statements
| Dec 2021 | 0 | -24.93M | |
|---|---|---|---|
| Mar 2022 | 0 | -27.24M | |
| Jun 2022 | 0 | -20.83M | |
| Sep 2022 | 0 | -20.36M |
| 2022-03-29 | -0.66 | -0.72 |
|---|---|---|
| 2022-08-15 | -0.76 | -0.58 |
| 2022-11-14 | -0.64 | -0.54 |
| Dec 2021 | 278755000 | 45.10M | 16.18% |
|---|---|---|---|
| Mar 2022 | 255958000 | 46.97M | 18.35% |
| Jun 2022 | 244537000 | 46.58M | 19.05% |
| Sep 2022 | 225509000 | 44.67M | 19.81% |
| Dec 2021 | -15.93M | 23.10M | 113K |
|---|---|---|---|
| Mar 2022 | -20.05M | -47.68M | 220K |
| Jun 2022 | -16.97M | 28.88M | 7.29M |
| Sep 2022 | -21.1M | 22.96M | -29K |
Akouos alternative data
| Aug 2023 | 103 |
|---|---|
| Sep 2023 | 103 |
| Oct 2023 | 103 |
| Nov 2023 | 103 |
| Dec 2023 | 103 |
| Jan 2024 | 103 |
| Feb 2024 | 103 |
| Apr 2024 | 103 |
| May 2024 | 103 |
| Jun 2024 | 103 |
| Jul 2024 | 103 |
Akouos other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2022 | 29992668 | 0 |
| Patent |
|---|
Application Filling date: 17 Mar 2022 Issue date: 25 Aug 2022 |
Application Filling date: 8 Apr 2021 Issue date: 10 Feb 2022 |
Application Filling date: 27 Sep 2019 Issue date: 6 Jan 2022 |
Application Filling date: 3 Aug 2021 Issue date: 25 Nov 2021 |
Application Filling date: 16 Jul 2021 Issue date: 25 Nov 2021 |
Application Filling date: 12 Jul 2019 Issue date: 28 Oct 2021 |
Application Filling date: 25 Jun 2019 Issue date: 9 Sep 2021 |
Application Filling date: 19 Dec 2018 Issue date: 11 Mar 2021 |
Application Filling date: 22 Feb 2019 Issue date: 17 Dec 2020 |
| Insider | Compensation |
|---|---|
Dr. Emmanuel Simons M.B.A., Ph.D. (1983) Co- Founder, Pres, Chief Executive Officer & Director | $697,550 |
| Ms. Jennifer Anne Wellman (1978) Chief Operating Officer | $527,850 |
| Ms. Sachiyo Minegishi (1978) Chief Financial Officer, Treasurer, Assistant Sec. & Principal Accounting Officer | $198,890 |
-
When is Akouos's next earnings date?
Unfortunately, Akouos's (AKUS) next earnings date is currently unknown.
-
Does Akouos pay dividends?
No, Akouos does not pay dividends.
-
What is Akouos's stock symbol?
Akouos, Inc. is traded on the NASDAQ under the ticker symbol "AKUS".
-
What is Akouos's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Akouos?
Shares of Akouos can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Akouos's key executives?
Akouos's management team includes the following people:
- Dr. Emmanuel Simons M.B.A., Ph.D. Co- Founder, Pres, Chief Executive Officer & Director(age: 42, pay: $697,550)
- Ms. Jennifer Anne Wellman Chief Operating Officer(age: 47, pay: $527,850)
- Ms. Sachiyo Minegishi Chief Financial Officer, Treasurer, Assistant Sec. & Principal Accounting Officer(age: 47, pay: $198,890)
-
Is Akouos founder-led company?
Yes, Akouos is a company led by its founder Dr. Emmanuel Simons M.B.A., Ph.D..
-
How many employees does Akouos have?
As Jul 2024, Akouos employs 103 workers.
-
When Akouos went public?
Akouos, Inc. is publicly traded company for more then 5 years since IPO on 26 Jun 2020.
-
What is Akouos's official website?
The official website for Akouos is akouos.com.
-
Where are Akouos's headquarters?
Akouos is headquartered at 645 Summer Street, Boston, MA.
-
How can i contact Akouos?
Akouos's mailing address is 645 Summer Street, Boston, MA and company can be reached via phone at 857 410 1818.
Akouos company profile:
Akouos, Inc.
akouos.comExchange:
NASDAQ
Full time employees:
103
Industry:
Biotechnology
Sector:
Healthcare
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
645 Summer Street
Boston, MA 02210
Boston, MA 02210
CIK: 0001722271
ISIN: US00973J1016
CUSIP: 00973J101
